DR Reddys Laboratories Limited Rituximab Export Data — India (DGFT 2022–2026)

Name: DR Reddys Laboratories Limited Rituximab Export Records India — #3 Exporter, 11 Shipments, $550.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

DR Reddys Laboratories Limited — Rituximab Exporter #3 | $550.0K Trade Value | TransData Nexus | TransData Nexus

DR Reddys Laboratories Limited — Rituximab Exporter Profile

Indian Pharmaceutical Exporter · #3 for Rituximab · $550.0K export value · DGFT Verified

DR Reddys Laboratories Limited is the #3 Indian exporter of Rituximab with $550.0K in export value and 11 verified shipments. DR Reddys Laboratories Limited holds a 2.9% market share in Rituximab exports across 5 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.

DR Reddys Laboratories Limited — Rituximab Export Profile: Buyers & Destinations

DR Reddys Laboratories Limited Rituximab export treemap — buyers and destination countries | TransData Nexus

Where Does DR Reddys Laboratories Limited Export Rituximab?

Country	Value	Shipments	Share
UNITED STATES	$142.9K	5	66.3%
RUSSIA	$50.5K	3	23.4%
INDONESIA	$14.2K	1	6.6%
MAURITIUS	$7.9K	1	3.6%
FINLAND

Who Are the Top Buyers of Rituximab from DR Reddys Laboratories Limited?

Buyer	Country	Value	Orders
UPS WAREHOUSE	UNITED STATES	$142.7K	4
JSC RPHARM	RUSSIA	$50.0K	1
PT FERRON PAR PHARMACEUTICALS JL JABABEKA VI BLOK	INDONESIA	$14.2K	1
HYPERPHARM LTD	MAURITIUS	$7.9K	1
JSC R-PHARM	RUSSIA	$468	2
ATTN MELISSA WHITE CHARLES RIVER LABORATORIES PA-BIOLOGICS TESTING SOLUTIONS	UNITED STATES	$250	1
NANOFORM FINLAND OY VIIKINKAARI	FINLAND	$48	1

DR Reddys Laboratories Limited supplies Rituximab to 7 buyers globally. The largest buyer is UPS WAREHOUSE (UNITED STATES), followed by JSC RPHARM (RUSSIA) and PT FERRON PAR PHARMACEUTICALS JL JABABEKA VI BLOK (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rituximab Formulations Does DR Reddys Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
RITUXIMAB PLACEBO 10MLQTY:4250 VIALSFOR TESTING PURPOSE ONLY	$50.0K	1
RITUXIMAB PLACEBO 50MLQTY:1986 VIALSFOR TESTING PURPOSE ONLY	$50.0K	1
RITUXIMAB WCBWORKING CELL BANKQTY:09VIALSNET QTY:27 GMS	$50.0K	1
RITUXIMAB DP 500MGQTY:30 VIALSFOR TESTING PURPOSE ONLY	$29.1K	1
REDDITUX 100MG/10ML RITUXIMAB INJECTION	$14.2K	1
RITUXIMAB DP 100MGQTY:70 VIALSFOR TESTING PURPOSE ONLY	$13.5K	1
REDDITUX 100 MG INJ RITUXIMAB INJECTION	$7.9K	1
INTERNAL REFERENCE STANDARDIRSRITUXIMAB0.5ML	$468	1
RITUXIMAB WORKING CELL BANK1 ML PER VIALQTY:10 VIALSAQ NOC NO:979/2023 DT:11.09.2023FOR TESTING USE ONLY	$250	1
RITUXIMAB DP 100MG02 VIALS	$48	1

DR Reddys Laboratories Limited exports 11 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RITUXIMAB PLACEBO 10MLQTY:4250 VIALSFOR TESTING PURPOSE ONLY with 1 shipments worth $50.0K.

How Does DR Reddys Laboratories Limited Compare to Nearest Rituximab Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$4.1M	102	18	$40.1K
1	DR.REDDY'S LABORATORIES LTD	$3.2M	64	17	$50.0K
3	DR REDDYS LABORATORIES LIMITED ★	$550.0K	11	5	$50.0K
5	HETERO BIOPHARMA LIMITED	$400.0K	8	4	$50.0K
4	MEDWISE OVERSEAS PRIVATE LIMITED	$250.0K	5	1	$50.0K

DR Reddys Laboratories Limited ranks #3 among 164 Indian Rituximab exporters. Average shipment value of $50.0K compared to the market average of $57.4K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Rituximab Exports?

Port	Shipments	% Share
SAHAR AIR	389	32.0%
SAHAR AIR CARGO ACC (INBOM4)	325	26.7%
Bombay Air	85	7.0%
Bombay Air Cargo	58	4.8%
HYDERABAD ACC (INHYD4)	46	3.8%
DELHI AIR CARGO ACC (INDEL4)	45	3.7%
DELHI AIR	35	2.9%
AHEMDABAD AIR	26	2.1%

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Rituximab Exports

The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.

Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)

However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 11 individual customs records matching DR Reddys Laboratories Limited exporting Rituximab, covering 11 formulations to 5 countries via 7 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 292+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rituximab

Rituximab

DR Reddys Laboratories Limited — Rituximab Exporter Profile

DR Reddys Laboratories Limited — Rituximab Export Profile: Buyers & Destinations

Where Does DR Reddys Laboratories Limited Export Rituximab?

Who Are the Top Buyers of Rituximab from DR Reddys Laboratories Limited?

What Is India's Total Rituximab Export Value and How Much Does DR Reddys Laboratories Limited Contribute?

What Is the Average Shipment Value for DR Reddys Laboratories Limited's Rituximab Exports?

How Does DR Reddys Laboratories Limited Compare to Other Indian Rituximab Exporters?

What Rituximab Formulations Does DR Reddys Laboratories Limited Export?

Regulatory Requirements: Exporting Rituximab to Key Markets

United States — FDA

How Does DR Reddys Laboratories Limited Compare to Nearest Rituximab Exporters?

Which Indian Ports Ship Rituximab Exports?

What Other Advanced Oncology Products Does DR Reddys Laboratories Limited Export?

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Rituximab Exports

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

About DR Reddys Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rituximab Export Data from DR Reddys Laboratories Limited

Rituximab Stats

Company Overview

Top Products by DR Reddys Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source